Your Location：
Home >
Browse articles >
Early monitoring of response to antimetabolic treatment of gemcitabine: A comparison of 18F-FLT and 18F-FDG uptake in Patu 8988 human pancreatic carcinoma cells
RADIOCHEMISTRY, RADIOPHARMACEUTICALS AND NUCLEAR MEDICINE | Updated：2021-01-29
Early monitoring of response to antimetabolic treatment of gemcitabine: A comparison of 18F-FLT and 18F-FDG uptake in Patu 8988 human pancreatic carcinoma cells
- Nuclear Science and Techniques Vol.22, Issue 5, (2011)
- DOI：10.13538/j.1001-8042/nst.22.293-298
Published：20 October 2011，
Received：07 March 2011
Scan the full text
Cite this article
0
Views
0
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album
Related Articles
Improving the detecting efficiency of suspected gastrointestinal tumors with dual-time-point 18F-FDG PET/CT
18F-FDG PET/CT in diagnosis of skeletal metastases
Comparison of diagnostic accuracy between 18F-FDG PET and PET/CT for pulmonary neoplasm
Related Author
Tai-Song Wang
Chang-Cun Liu
Wen-Li Qiao
Xiang Chen
Yan Xing
Xue-Qian Xie
Jin-Hua Zhao
Jian-Hua Song
Related Institution
Haining Rd
Department of Nuclear Medicine, No.1 Hospital Affiliated to China Medical University
Department of Urinary, No.1 Hospital Affiliated to China Medical University
Department of PET/CT Center, No.1 Hospital Affiliated to Guangzhou Medical College
Department of Nuclear Medicine, The Chinese PLA General Hospital
0